benzonatate
- Product NDC
- 67877-128
- 11-digit product format
- 678770128
- Labeler code
- 67877
- Product ID
- 67877-128_de64cd7e-65b6-4ba2-8ed7-a1c98f2cca4e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Ascend Laboratories LLC
- Application
- ANDA201209
- Marketing category
- ANDA
- Marketing start
- 2015-02-09
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dc429dc2-e942-6686-8d72-b63c57e806aa | Product name | 5 | 20190416 |
| d45c2ed6-126c-dd22-afd2-e29a2ecf77b9 | Product name | 3 | 20190215 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67877-128-01 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-1638-fd44-e053-dadaa90aa01b | Benzonatate Capsules, USP 100 mg, 150 mg and 200 mg |
| 67877-128-05 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-1638-fd44-e053-dadaa90aa01b | Benzonatate Capsules, USP 100 mg, 150 mg and 200 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67877-128-01 | benzonatate | 100 in 1 BOTTLE | CAPSULE | 100 | 13 | |
| 67877-128-05 | benzonatate | 500 in 1 BOTTLE | CAPSULE | 500 | 13 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67877-128-01 | EA - Each | 67877-128 | d93fc4c9-c1eb-4b7a-b97e-e73d2b946b18 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| benzonatate | ACTIVE INGREDIENT | 5P4DHS6ENR | BENZONATATE CAPSULE [ASCEND LABORATORIES LLC] | 11 | |
| benzonatate | ACTIVE MOIETY | 5P4DHS6ENR | BENZONATATE CAPSULE [ASCEND LABORATORIES LLC] | 11 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | BENZONATATE CAPSULE [ASCEND LABORATORIES LLC] | 11 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | BENZONATATE CAPSULE [ASCEND LABORATORIES LLC] | 11 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | BENZONATATE CAPSULE [ASCEND LABORATORIES LLC] | 11 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | BENZONATATE CAPSULE [ASCEND LABORATORIES LLC] | 11 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | BENZONATATE CAPSULE [ASCEND LABORATORIES LLC] | 11 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | BENZONATATE CAPSULE [ASCEND LABORATORIES LLC] | 11 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | BENZONATATE CAPSULE [ASCEND LABORATORIES LLC] | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197397 | benzonatate 100 MG Oral Capsule | PSN | 27388883-e698-4501-b8c9-78c76ae9b1e1 | 13 |
| 903291 | benzonatate 150 MG Oral Capsule | PSN | 27388883-e698-4501-b8c9-78c76ae9b1e1 | 13 |
| 283417 | benzonatate 200 MG Oral Capsule | PSN | 27388883-e698-4501-b8c9-78c76ae9b1e1 | 13 |
| 197397 | benzonatate 100 MG Oral Capsule | SCD | 27388883-e698-4501-b8c9-78c76ae9b1e1 | 13 |
| 903291 | benzonatate 150 MG Oral Capsule | SCD | 27388883-e698-4501-b8c9-78c76ae9b1e1 | 13 |
| 283417 | benzonatate 200 MG Oral Capsule | SCD | 27388883-e698-4501-b8c9-78c76ae9b1e1 | 13 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67877-128-01 | 67877012801 | 100 CAPSULE in 1 BOTTLE (67877-128-01) | 100 capsule | 2015-02-09 | 0000-00-00 | No | No | Current |
| 67877-128-05 | 67877012805 | 500 CAPSULE in 1 BOTTLE (67877-128-05) | 500 capsule | 2015-02-09 | 0000-00-00 | No | No | Current |